CROWN BIOSCIENCE (TAIWAN) INC.
Update：2025/12/03
Industries
Main Industry
Biotechnology
Main Product/Service
We are known for our high-quality integrated solutions. From in vivo to in vitro, ex vivo, and in silico services, we work closely with our clients to assess the efficacy and pharmacological profile of their drug candidates before clinical development. Our aim is to deliver superior drug candidates to ensure that patients get the right treatment at the right time.
Founded Year
2016
Unified Business No.
43777419
Status
Active
Number of Employees
0
Total Paid-in
Capital
16,163,700 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Headquartered in California, US, Crown Bioscience is a global contract research organization (CRO) providing discovery, preclinical and translational platforms and services to advance oncology and immuno-oncology.
